85 related articles for article (PubMed ID: 7541924)
1. The importance of dose intensity in chemotherapy of advanced testicular cancer.
Miyanaga N; Akaza H; Hattori K; Takeshima H; Koiso K
Urol Int; 1995; 54(4):220-5. PubMed ID: 7541924
[TBL] [Abstract][Full Text] [Related]
2. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
4. [Treatment results and practical dosage of PVB therapy for advanced testicular tumors].
Seguchi T; Iwasaki A; Sugao H; Nakano E; Sonoda T
Nihon Hinyokika Gakkai Zasshi; 1990 Sep; 81(9):1357-61. PubMed ID: 1700180
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
[TBL] [Abstract][Full Text] [Related]
6. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
[TBL] [Abstract][Full Text] [Related]
7. [PVB therapy for advanced testicular cancer].
Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Miyakoda K
Hinyokika Kiyo; 1989 Nov; 35(11):1871-5. PubMed ID: 2482672
[TBL] [Abstract][Full Text] [Related]
8. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
[TBL] [Abstract][Full Text] [Related]
9. Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
de Wit R; Stoter G; Sleijfer DT; Kaye SB; de Mulder PH; ten Bokkel Huinink WW; Spaander PJ; de Pauw M; Sylvester R
Br J Cancer; 1995 Jun; 71(6):1311-4. PubMed ID: 7540039
[TBL] [Abstract][Full Text] [Related]
10. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
Gutierrez-Delgado F; Titov DA; Tjulandin SA; Garin AM
Neoplasma; 1999; 46(3):190-5. PubMed ID: 10613596
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
[TBL] [Abstract][Full Text] [Related]
12. [A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors].
Fukui I; Komatsubara S; Akaza H; Sakashita S; Akasaka Y; Tobisu K; Yamauchi T; Deguchi N; Furuhata A; Kawai T
Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):976-83. PubMed ID: 1715416
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of prostatic cancer].
Hirao Y; Kubota K; Yoshie T; Tabata S; Samma S; Ozono S; Okajima E; Sasaki K; Yoshikawa M; Tsumatani K
Hinyokika Kiyo; 1991 Aug; 37(8):817-24. PubMed ID: 1720273
[TBL] [Abstract][Full Text] [Related]
14. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
15. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of advanced testicular cancer].
Murase T; Takashi M; Sobashima T; Shimoji T; Miyake K; Mitsuya H
Hinyokika Kiyo; 1987 Jan; 33(1):47-50. PubMed ID: 2437779
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of testicular cancer: 10-year experience.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
[TBL] [Abstract][Full Text] [Related]
19. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of chemotherapy in urologic cancer].
Miki T; Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1349-57. PubMed ID: 2471457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]